WS No. 10 Patterns of Care DX Year 2007

WS No. 10 护理模式 DX 2007 年

• 批准号: 7698375
• 金额: $ 15.01万
• 依托单位: PUBLIC HEALTH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7698375
• 关键词: WS; No.; 10; Patterns; Care

The objectives of the Patterns of Care Study are to: 1) describe the use of adjuvant therapy, which will be verified with the treating physician; 2) characterize the practice patterns in different communities; 3) describe more completely the use of surgery as treatment; 4) compare the patterns of treatment (surgery, radiation therapy, chemotherapy, hormonal therapy) over time and by age and race/ethnicity; 5) describe the effect of co-morbid conditions on treatment, and 6) describe treatment by hospital characteristics (i.e., profit vs. not for profit, teaching vs. non-teaching, bed size, etc.) in different geographic areas of the United States. Patterns of Care Studies are conducted to satisfy a Congressional directive (under Public Law 100-607, Sec. 413 (a)(2)(C) adopted November 4, 1988) to the National Cancer Institute to ¿assess the incorporation of state-of-the-art cancer treatments into clinical practice and the extent to which cancer patients receive such treatments and include the results of such assessment in the biennial reports¿¿. To select the cancers sites the Division of Cancer Control and Population Sciences has been working closely with the Division of Cancer Treatment. This year's Pattern's of Care (POC) Study will investigate state-of-the-art therapies for small cell lung cancer, acute myeloid leukemia, multiple myeloma, and hepatocellular carcinoma.

护理模式研究的目的是：1）描述辅助治疗的使用，这将与治疗医生进行验证; 2）描述不同社区的实践模式; 3）更完整地描述手术治疗的使用; 4）比较治疗模式（手术、放射疗法、化学疗法、激素疗法）随时间的变化以及按年龄和种族/民族分类; 5）描述共病状况对治疗的影响，以及6）按医院特征描述治疗（即，营利与非营利、教学与非教学、床位大小等）在美国不同的地理区域。护理模式的研究是为了满足国会的指令（根据公法100-607，第100节）。413（a）（2）（C）通过1988年11月4日），以国家癌症研究所评估纳入最先进的癌症治疗的临床实践和癌症患者接受此类治疗的程度，并将此类评估的结果纳入两年期报告中。为了选择癌症地点，癌症控制和人口科学司一直与癌症治疗司密切合作。今年的护理模式（POC）研究将调查小细胞肺癌，急性髓性白血病，多发性骨髓瘤和肝细胞癌的最先进疗法。